Podcasts about global medicine

Monica Gandhi, MD, reflects on her decades-long work in HIV care, from providing care early in the epidemic to leading implementation of today's groundbreaking medical advances. She discusses the science behind HIV (including how 7 people have been cured), the groundbreaking shift from complex pill regimes to long-acting injectable therapies, and how these innovations help patients facing medication challenges. Monica also draws parallels to COVID-19 as she underscores the importance of harm reduction; encourages bipartisan support while talking about policy and funding; addresses social determinants of health that impact HIV prevention and treatment. For her, HIV is not just an infection, but a movement driving healthcare and equity forward.  Read the transcript of the episode. Connect with Dr. Monica Gandhi on Twitter and LinkedIn  Endemic, by Monica Gandhi  CAPTC HIV & PrEP Resources  Long-Acting Injectable PrEP  Previous episode with Dr. Monica Gandhi: S1 E7: How Effective Are COVID-19 Vaccines? with Dr. Monica Gandhi  Monica Gandhi, MD, MPH, is a Professor of Medicine and an Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco. She is the director of the UCSF Center for AIDS Research and the Medical Director of the HIV clinic (Ward 86) at SF General Hospital. Dr. Gandhi also serves as the Associate Program Director of the Infectious Diseases Fellowship at UCSF. Her research focuses on HIV treatment and prevention optimization, HIV in women, adherence measurements in HIV and tuberculosis, adherence interventions, and optimizing the use of long-acting antiretroviral therapy. Dr. Gandhi has been in the HIV workforce since 1996 and brings an extremely important level of expertise to the field. Her book, Endemic, illustrates the lessons to be learned and applied to future epidemics from the HIV epidemic.   Have any questions, concerns, or love letters? Send us a message on Instagram @comingtogetherpod or email us at captc@ucsf.edu  Don't forget to leave us a review on Spotify, or wherever you get your podcasts.  

Our guest today is our very own, Dr. Monica Gandhi, a distinguished expert in HIV and infectious diseases. She is a Professor of Medicine at UCSF and the Associate Division Chief of HIV, Infectious Diseases, and Global Medicine at the Zuckerberg San Francisco General Hospital, overseeing significant research and clinical operations. Dr. Gandhi's unique perspective is shaped by her extensive work in HIV research and her pivotal role in public health education. Through her groundbreaking efforts, she has pioneered low-cost solutions for antiretroviral measurements and advanced treatment strategies for women with HIV. She plays a crucial role in public health education, mentoring early-career researchers, and addressing the COVID-19 pandemic through her writing and public outreach. In this episode, we explore the state of people's trust in healthcare, Dr. Gandhi's insights into the intersection of collectivism and health, and her vision for rebuilding authority in public health institutions. Do you have any thoughts or guest suggestions? Please email us at hello@rosenmaninstitute.org.

Health policy refers to the decisions, plans, and actions taken to achieve specific health care goals within a society. Globally, health policy plays a pivotal role in addressing issues such as infectious diseases, access to care, and preventive health services. However, disparities persist, particularly in low- and middle-income communities, where funding constraints and misaligned priorities can significantly impact health outcomes. In S7E18, internal medicine resident Siale Teaupa joins Hạ and Alizah to discuss the complex world of health policy and global health. They explore how global health policies shape medical practices, the challenges arising from limited funding and resource allocation, and the changes needed to create more equitable and effective healthcare systems worldwide.

Neda Nikpoor, MD, and Neda Shamie, MD, interview Geoffrey Tabin, MD, cofounder of Cure Blindness Project and a Professor of Ophthalmology and Global Medicine at Stanford University. Dr. Tabin shares his inspiring journey from witnessing the transformative impact of cataract surgery in Nepal to dedicating his life to combating preventable blindness worldwide. They discuss how he and Sanduk Ruit, MD, established sustainable eye care systems by training local surgeons, implementing a model where paying patients subsidize free care, and maintaining high-quality, high-volume surgeries. The conversation explores challenges faced in different regions, strategies for sustainable medical missions, and practical ways medical professionals can contribute to global eye care efforts. 

YouTube Version https://youtu.be/TwCxKSIznb4 https://youtu.be/TwCxKSIznb4 Youtube Version Dr. Kim Tranquada, MD, FACEP, CEO and Founder of Healthcare Alliance for an Equitable World Dr. Kim Tranquada is an Emergency Physician with 25 years of experience. Kim has worked in a variety of clinical settings in the United States, from academic tertiary care medical centers, suburban medical centers, rural critical access hospitals, to tribal healthcare facilities. Dr. Tranquada has led and developed several programs, from emergency ultrasound, a novel medical Spanish and cultural competency residency program, to innovating and implementing tele-emergency care within the largest integrated medical system in the US. Kim is an accomplished leader, a trained leadership coach and is passionate about building a values-driven organization that embodies global diversity, equity, inclusion, and access.

In this episode, Dr. Steven Fine discusses some of the latest data that might be used to support starting patients who are unable to take oral antiretroviral medications on long acting, injectable ARV. Patients who consider this off label use because their HIV viral load was not suppressed on oral treatment would have to be carefully selected and well supported. Related Content:  Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy. James B. Brock, Peyton Herrington, Melissa Hickman, and Aubri Hickman. Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center. Jackson, Mississippi, USA. Clinical Infectious Diseases, Volume 78, Issue 1, 15 January 2024, Pages 122–124, https://doi.org/10.1093/cid/ciad511 CROI 2024: Abstract number 628 24 Week Viral Suppression in Patients Starting Long-Acting CAB/RPV Without HIV Viral Suppression. Matthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, Elizabeth Imbert, John D. Szumowski, Jon Oskarsson, Mary Shiels, Samantha Dilworth, Ayesha Appa, Diane V Havlir, Monica Gandhi, Katerina Christopoulos. Division of HIV, Infectious Disease, & Global Medicine, University of California, San Francisco, CA, United States. CROI 2024: ABSTRACT NUMBER 212. SESSION TITLE. Special Session. Clinical Late-Breaking Oral Abstracts. SESSION NUMBER Oral Session-14. Long-Acting Injectable CAB/RPV is Superior to Oral ART in PWH With Adherence Challenges: ACTG A5359. Aadia I. Rana, Yajing Bao, Lu Zheng, Sara Sieczkarski, Jordan E. Lake, Carl J. Fichtenbaum, Tia Morton, Lawrence Fox, Paul Wannamaker, Jose R. Castillo-Mancilla, Kati Vandermeulen, Chanelle Wimbish, Karen T. Tashima, Raphael J. Landovitz CEI toll free line for NYS providers: 866-637-2342 https://ceitraining.org/

Ever wondered at what age you should start considering Botox, or if "baby Botox" could actually hold the key to preventing wrinkles? This episode promises to shed light on these burning questions. We take you inside Divina Dermatology and Cosmetics Center for an insightful discussion with my dermatologist, Dr. Hakim. We don't just stop at Botox; we're opening the Pandora's box of cosmetic procedures and the secrets to maintaining that elusive youthful glow, even tackling the personalized skincare regimen  Our chat goes beyond the surface, literally and metaphorically. Tune in for an episode that's not just skin-deep. Dr. Jacquiline Habashy Hakim's IG:@beverlyhillsdermhttps://www.divinadermatology.comDr. Habashy Hakim Double Board-Certified Dermatologist & Cosmetic SpecialistDr. Habashy Hakim earned both her Bachelor of Science and Master of Science degrees at the prestigious University of Southern California. Her primary focus was on Health Promotion and Disease Prevention, supplemented by a minor in Biology. She further honed her expertise with a Master's degree in Global Medicine.Subsequently, Dr. Hakim pursued her medical education at Western University of Health Sciences. Her outstanding leadership and academic achievements during medical school led her to the prestigious position of President of the Dermatology Society. For her Dermatology residency, Dr. Hakim underwent training in Miami, Florida, where she had the opportunity to learn from renowned experts in cosmetic, surgical, and medical dermatology. As a senior resident, she played a crucial role as a key opinion leader in aesthetic medicine for Doctors Reaching for Excellence and Achievement in Medicine.Dr. Hakim is deeply involved in the dermatology community and holds membership and advisory positions in several professional organizations, including the American Academy of Dermatology (AAD), the Women's Dermatology Society (WDS), the American Society of Dermatologic Surgery (ASDS), and the Skin of Color Society (SOCS). Her expertise has been recognized through numerous publications in esteemed peer-reviewed journals and presentations at prestigious conferences nationwide. In her practice, Dr. Hakim specializes in cosmetic, surgical, and medical dermatology. Her commitment to providing top-notch care is evident in her approach, treating every patient with the same level of attention and care as she would her family. Dr. Hakim is renowned for her ability to produce natural and transformative results, leaving her patients feeling and looking their best selves.You can watch the full episodes on our YoutubeYoutube - ConfessionsofawannabeitgirlConfessions of A Wannabe It Girl's TikTok:@wannabeitgirlpodcast Confessions of A Wannabe It Girl's IG:@confessionsofawannabeitgirl

Episode 9 - Understanding The Implementation of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and Addressing Sexually Transmitted Infections with Dr Annie Luetkemeyer In this episode of Going anti-Viral, Dr Michael Saag has an insightful discussion with Dr Annie Luetkemeyer, a professor of medicine in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General at the University of California San Francisco.  Centering around the state of sexually transmitted infections in the United States, rising cases, strategies for control, and the promising role of doxycycline post-exposure prophylaxis (DoxyPEP)00:02 Introduction to the Podcast01:31 Discussion on the State of Sexually Transmitted Infections05:21 Exploring the Concept of Post-Exposure Prophylaxis07:19 Understanding the Implementation of DoxyPEP10:23 Effectiveness of DoxyPEP17:41 Potential Side Effects and Concerns of DoxyPEP22:37 Future Prospects of DoxyPEP in STI Prevention28:04 Conclusion and Final Thoughts28:46 Podcast Closing Remarks__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTube InstagramTikTok...

Professor Geoffrey Tabin MD is Co-Founder and Chairman of the Himalayan Cataract Project, Professor of Ophthalmology and Global Medicine at Stanford University, and a world class mountaineer who has climbed the tallest peaks on earth. His passion is treating blindness worldwide, primarily through his work teaching and performing cataract surgery. You can learn more about his project CureBlindess.org via this link. He is an amazing and dynamic man who brings an infectious enthusiasm and inspiration to countless ophthalmologists like me. I am confident that you will love this podcast. We feature a new podcast every week on Sundays and they are uploaded to all major podcast services (click links here: Apple, Google, Spotify) for enjoying as you drive to work or exercise. I am really excited to share these amazing podcasts with you. The full video of the podcast will also be here on CataractCoach as well as on our YouTube channel. Our podcast is now sponsored by Harrow, Inc and we are thankful for their support.

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/east-asian-studies

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/military-history

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/chinese-studies

Today I talked to Wayne Soon about his book Global Medicine in China: A Diasporic History (Stanford UP, 2020). In 1938, one year into the Second Sino-Japanese War, the Chinese military found itself in dire medical straits. Soldiers were suffering from deadly illnesses, and were unable to receive blood transfusions for their wounds. The urgent need for medical assistance prompted an unprecedented flowering of scientific knowledge in China and Taiwan throughout the twentieth century. Wayne Soon draws on archives from three continents to argue that Overseas Chinese were key to this development, utilizing their global connections and diasporic links to procure much-needed money, supplies, and medical expertise. The remarkable expansion of care and education that they spurred saved more than four million lives and trained more than fifteen thousand medical personnel. Moreover, the introduction of military medicine shifted biomedicine out of elite, urban civilian institutions and laboratories and transformed it into an adaptive field-based practice for all. Universal care, practical medical education, and mobile medicine are all lasting legacies of this effort. Wayne Soon is an Associate Professor in the Program of the History of Medicine in the Department of Surgery and the Program of History of Science, Medicine, and Technology at the University of Minnesota. Dr. Soon is a historian of medicine as well as modern China and Taiwan, with an interest in how international ideas and practices of medicine, institutional building, and diaspora have shaped Chinese East Asia's interaction with its people and the world in the twentieth century. He has published scholarly articles in Bulletin of the History of Medicine, Twentieth Century China, American Journal of Chinese Studies, and East Asian Science, Technology and Society: An International Journal. Li-Ping Chen is a teaching fellow in the Department of East Asian Languages and Cultures at the University of Southern California. Her research interests include literary translingualism, diaspora, and nativism in Sinophone, inter-Asian, and transpacific contexts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Drs. John Sweetenham and Lawrence Shulman discuss the challenges that oncologists will be confronting in 2024 and share insights on how to build clinician resilience and optimize the oncology workforce to provide better, safer care for patients with cancer. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham from the UT Southwestern Harold C. Simmons Comprehensive Cancer Center and host of the ASCO Daily News Podcast. I'm thrilled to welcome my friend and colleague, Dr. Larry Shulman, to the podcast today. Dr. Shulman is a professor of medicine, associate director of special projects, and the director of the Center for Global Medicine at the University of Pennsylvania Abramson Cancer Center. Dr. Shulman is also the immediate past chair of the Commission on Cancer, and also serves on the National Cancer Policy Forum of the National Academies of Science, Engineering, and Medicine. His acclaimed research has led to the development of models of clinical care to improve the patient experience and quality of care in the United States and internationally. His activities have also included innovations in health information technology, cancer survivorship care, and some other related areas. Today, Dr. Shulman will be sharing his valuable insights on some of the growing complexities and challenges that we'll be grappling with in oncology in 2024 and beyond, and potential solutions to address these issues. You'll find our four disclosures in the transcript of this episode, and disclosures of all guests on the podcasts are available at asco.org/DNpod. Larry, it's great to have you on the podcast today. Dr. Lawrence Shulman: Thank you so much, John. Dr. John Sweetenham: To start with Larry, as you know, the growth in the number of patients with cancer and cancer survivors in the U.S. is greatly outpacing the number of clinicians available to care for them. The American Association for Cancer Research, for example, estimates that there will be nearly 2 million new cancer cases in the U.S. alone this year and that the number will increase significantly in the years to come. The number of cancer survivors in total in the U.S. is predicted to grow to around 20.3 million by 2026. So, the question our community has been grappling with for some time now is: “How do we confront these realities and provide optimal care for patients, while at the same time building the resilience of the clinicians who need to care for them?” This is an area I know that you've focused on for a long time and you've published several papers in recent years as well as the great work that you've done as co-chair of the National Cancer Policy Forum workshop on the oncology workforce. Can you share your insights into some of these challenges? Dr. Lawrence Shulman: Sure, John. Thank you very much. As you mentioned, the number of oncologists in this country is pretty stable. There's consistent but relatively low number entering the workforce and those of us who were really in the first wave of oncologists in the 1970s are beginning to retire. A number of years ago we thought, well, we need to figure out ways to recruit more medical students and trainees into the field of oncology, but that's clearly not going to happen. And as you also mentioned, the number of cancer patients is rapidly increasing in this country, partly because of the aging population and partly because frankly we're better at treating them. The cure rates are better, and the number of survivors is going up. So, the math is pretty straightforward. We have a relatively stable number of oncology providers trying to care for a rapidly increasing number of patients and that's just not going to change. So, we need to have plan B; we need to figure out how we can better meet the needs in this country. And I think all of us who practice are feeling the strain of trying to take care of these increasing number of patients. I think there are a few things that are contributing to this as well. One—the good news is we have lots of new therapies, we have lots of genomics, which are leading us to better tailor therapies for our patients. But this is all complicated and it's a lot for us all to learn and keep abreast of and to manage on a day-to-day basis in the middle of a busy clinic. But the other thing is that I believe our care has become progressively more inefficient, making it harder every day that we go to clinic to care for the number of patients we need to. And that really has to change. For those of us who've been doing this for a long time, and I know you have as well, this has been a trend really over decades. It's gone in the wrong direction. It was a lot easier to practice a number of decades ago. Now, the requirements for documentation and pre-authorization and many other administrative tasks has just grown progressively over these years. And we need to figure out how to change that. And in addition, our electronic health records, which is where we live in clinic, have been remarkable and wonderful in many ways, but are also inefficient to use and we need to do a better job in optimizing their functionality. Dr. John Sweetenham: Great, thanks Larry. I do agree with you there and I think that in addition to the challenges of running the electronic health record and using that at the point of care, of course the other thing that many of our clinicians face now is an increasingly complex treatment landscape and a greater need for clinical decision support tools, which of course are not always at the moment quite as facile as we would like them to be. And I think partly because of that, many oncologists are feeling overburdened partly with these various administrative tasks they have, partly with frankly keeping up with their own specialty areas or if they're community-based general oncologists, just keeping up in general with the new information that's coming at them. And then add on top of all of that the emotional toll of caring for patients with cancer. And not surprisingly, perhaps I think we have started to see, certainly we have experienced an exodus of some oncologists in recent years who've decided to pursue careers outside of direct patient care and oncology. And those included some moving into other areas of academia, some going into industry, some going into various tech companies and so on. Are you concerned that we all struggle in the effort of building and support a resilient oncology workforce to meet the needs of this growing population that you mentioned? Dr. Lawrence Shulman: Yeah, I'm very concerned about that, John. And I think one way to think about this is that as you say, the practice of oncology inherently is a stressful and difficult, though quite rewarding way to spend your professional career. But we layer on top of that a lot of frustration and difficulties that really don't need to exist. And when I think about this, I think about really two buckets. There's a bucket of factors that are within our control in an individual institution or an individual practice, and I'll come back to that in a minute. The other bucket are external forces, things that are required by the government regulators, by the payers that need to be done in routine practice. We have less direct influence over those, though I think it's a profession, we need to think hard about how to influence the external factors as well. At the practice level, there are a lot of things that we can do. One has to do with optimizing our electronic health record, which does have, in most cases, the ability to have it customized by institution in a way that would make it optimal. And some of that again, is external because we're dealing with a vendor product that has some limited ability to be customized, but we need to do a better job of the technology that underlies our practice every day when we go to clinic. The other major factor in support, whether it's advanced practice providers, nurses, medical assistants, navigators, and other personnel who can in fact help to support the patients, help to support their families, and help to support the clinicians who are on the front line trying to care for these patients. And we all use the term, practicing at the top of your license and aspire to that. But I think frankly we don't do a great job in that regard, and we need to really think harder about how we do have the appropriate team around us. In addition, I would say that there are a lot of other things at the practice level that we need to think about, including the facility of ordering radiologic studies and consultations and so on, all of which are often more cumbersome than they should be. We really need to not put these obstacles in the way of our clinicians. Externally, I think we need to get the payers and to get the government CMS to understand that the current state, it's just not going to be viable going forward and they need to make some big changes. And I think one of the ways to think about this is that rather than doing something differently, you want to do a different thing. I mean, they really need to make some paradigm changes and what's required day in and day out from our clinicians. Dr. John Sweetenham: Absolutely. So, I want to pick up on something that you mentioned there, which is the role of navigators and the benefits that navigation, patient navigation, can have in several domains, but certainly it can help to reduce the burden on oncologists and strain in the system in general. But to take that a little bit further, I wonder if we could talk a little bit about how navigation can help in reducing care disparities. You were saying before we came on the podcast today, the concept of using patient navigators to reduce disparities in care is not new. It's been around for many, many years, but it seems like we almost have to keep relearning that they really help in terms of reducing various disparities which may be rural disparities, racial and ethnic and so on. There are plenty of data out there, as you've mentioned, just to quote a couple of studies, there was the ACCURE trial published a couple of years ago now, which was really a multi-pronged intervention to help Black patients overcome obstacles to completion of treatment. And it included navigation along with a number of other interventions, electronic health record flags to alert caregivers to missed appointments, providers to missed appointments, I should say. It also included physician champions to help engage the health care teams and some educational interventions as well with a significant impact on the access to care from Black patients. The Levine Cancer Institute in the Carolinas conducted a study in my own world, in aggressive large B-cell lymphoma a number of years ago, where they showed that they were able to navigate all of their patients into guideline-concordant care, which essentially eliminated the disparity in outcome between Black and White patients in their population. And then more recently, a study from the University of Maryland looked at Black men with prostate cancer and demonstrated that with the intervention from a navigator, the number of those patients who had their appropriate genetic testing was increased enormously to levels which were comparable with the White patients in their community. No clear evidence yet that that's impacted outcome, although intuitively, I think it would, but nevertheless, as you've already pointed out, there is a ton of evidence that navigation can help us to eliminate disparities. Could you talk a little bit about your own insights into that area and the work that you've done? Dr. Lawrence Shulman: Sure. A few years ago, the National Cancer Policy Forum held a workshop on navigation in cancer and we spent a couple of days in Washington going over many of the studies you've mentioned. And one of our speakers was Harold Freeman, who was a surgeon in Harlem. About 60 years ago, he showed that patient navigation could reduce disparities in cancer care in his setting. And I think the surprising and somewhat disappointing aspect of this is, well, we have a new therapy, whether it's immunotherapy or whatever that is shown to improve overall survival and outcomes. We adopt that, and we start using it. And yet here something that's relatively straightforward, patient navigation, which has been shown as you say, to improve access to care, to improve guideline-concordant diagnostics, guideline-concordant treatment, patient satisfaction, and ultimately improve outcomes and reduce disparities, but has not been embraced in the same way that new therapies have been embraced. And from my point of view, these factors are equally important. They translate in the patient outcomes ultimately just like the therapies that we choose to. And we need to really buy into that. We need to understand that this really affects our patient outcomes as much as our therapies do. So, a couple of things. One is that you've already mentioned the different ways that navigation might improve outcomes, and that's clearly the case. But there are other aspects which are really critical to a lot of conversations we've been having, and that is that navigators fill vital roles that when they're not present are often filled by the treating physician, trying to make sure that the diagnostic tests, the genomics are all done, trying to make sure that the patient is getting their radiologic studies on time, trying to make sure that the appropriate appointments are being set up. Navigators are very, very good at doing this. They're very good at bonding to the patients and helping the patients feel secure through this cancer journey. But if they're not there, either those things don't get done or the clinician, the treating physician or the advanced practice provider is doing that. And so, it has the dual effect of both burdening clinicians who really have another role in the care of the patients doing these other scheduling and navigation functions as well as improving the overall care. I will say that in my own experience, it's important to have navigators who are skilled in their areas, that understand the diseases that we're treating, that understand the patient's needs in relation to those diseases and the treatments and diagnostics that we have to offer. So, there is a real skill to navigation, but a skilled navigator really makes a huge difference to the patient. And again, not only in the very tangible ways that you mentioned, but also frankly in the psychological security of the patient. And patients will tell you this and there are surveys out there that show this, that patients who are undergoing a new diagnosis of cancer are terrified, do much better psychologically when they have a navigator at their side through this journey. But it has tremendous benefit to the clinicians as well. And why haven't we embraced navigators? I can only speculate, but one of the comments that I get from health system administrators is, “Well, they cost a lot of money, and their work is not reimbursed as part of health care reimbursement.” But there is, again, overwhelming evidence to show that the return on investment for navigators is substantial. And it's substantial because it keeps patients in your practice, it provides more efficient care at all levels. And we published out of the National Cancer Policy Forum work, an article that basically shows from a variety of different centers, including mine at Penn, that there is a tremendous ROI for having navigators. So yeah, it's a little bit of money upfront to hire them, but ultimately, it's a good thing financially as well as clinically. Dr. John Sweetenham: Yeah. So often with these kind of wraparound services that are so important to our patients showing and being able to clearly demonstrate the kind of downstream revenue from those services is difficult, but is I think probably evident to those of us who are in the clinic and see what happens. So, maybe we need some more sophisticated financial models to be able to highlight that to our leaders in the health systems, I think that the evidence is really quite clear. So, Larry, one of the disparities that you've mentioned, and perhaps we haven't focused on quite so much in this discussion, has been the issue of cancer care for rural versus urban communities. And I think it's important that we highlight the challenges that oncologists are facing in rural communities across the country in caring for patients who live many miles away from a hospital or clinical practice and where the oncologists do not have the kind of support system that you'd find in an academic center in a major city. Can you comment a little on that? Lawrence Shulman: Sure, John. This is a real problem. I and others have published on cancer survival statistics in rural settings and in small community hospitals and they are in fact inferior to larger academic cancer centers, probably for a multitude of reasons. And one of our colleagues, Dr. Otis Brawley, made the comment a number of years ago and still repeats it, that your likelihood of surviving cancer in the U.S. is more tightly linked to your ZIP code than your genetic code. And there is some truth to that. Now, there are tremendous challenges for providing cancer care in a small, rural hospital. We practice in academic medical centers; I'm a breast cancer doctor and I spend all of my time trying to stay current in breast cancer. And it's a field that's changing rapidly. It's hard for me to imagine how my colleagues who are generalists in the community are keeping up with the advances in so many different diseases. And I think frankly, it's really, really hard to do that. In addition, all of us at academic centers have weekly tumor boards. We get to ask our colleagues what their thoughts are about our difficult cases. We get a lot of input from pathologists, radiologists, and other colleagues. And frequently clinicians, physicians, oncologists, practicing in rural hospitals don't have that constituency around them for them to bounce difficult patients off of to try to figure out what the best approach might be for a patient. So, the differences are terrific, and the support is just not there. This is something that our country has not really confronted. We have a very big country geographically. Some of the areas of the country are quite rural. A patient can't be expected to travel four hours in each direction to an academic cancer center. We need to figure out how to better partner between our academic cancer centers and our community colleagues to support their care in ways that we've not done routinely up to this point. I know that the National Cancer Institute is very interested in this and trying to figure it out. But again, I think we have to feel a collective responsibility to support our colleagues in the community. They try really hard, they're working really hard, they're doing the best they can, but they just don't have the support that we have in academic cancer centers. Dr. John Sweetenham: Yeah, sure. Before we wrap up the podcast today, I'd like to circle back a little to something that you said earlier and a topic that I know that you've published about quite extensively in the past and that's the issue of health care technology. And I think we probably all agree that health care's been a little bit slow to capitalize on technology to improve our care processes and outcomes. And your research has highlighted that technology can facilitate patient-clinician interactions in a number of ways through augmented intelligence, texting, chatbots, among other things. Can you tell us a little bit about this, how you think that AI might be able to help us in the future to streamline the management of some of these medical and administrative issues that we've been talking about today? Dr. Lawrence Shulman: Sure, John. It's hard to turn the TV on or read a newspaper without an article on artificial intelligence. But the word you used is the word that I use, which is augmented intelligence. I don't think we're looking to replace clinicians with technology, but we're looking to in fact make their jobs easier, to remove some of the tasks that they don't need to do themselves as really an assistant, if you will, another assistant. We have used technology extremely poorly in the medical profession overall. I'm not quite sure why that is. But if you look at the banking industry or other industries, they've used technology tremendously well with great benefit, benefit not only for the people who are using the services, in our case, the patients, but also those who are providing the services, in our case, the clinicians. So, I think we need to do a better job. We need to have electronic health records that are in fact helping rather than sometimes hindering or making frustrating the care of the patients. We need to use artificial intelligence or augmented intelligence to interact with patients and help to manage them. We're using augmented intelligence chatbots to manage patients who are on oral chemotherapy able to do a lot of the tasks that normally the clinicians would be doing without in any way jeopardizing the safety or the well-being of the patients. The patients actually tell us that they like this, that it's just another way to feel connected to their practice in a way that's efficient and easy for them through texting rather than sometimes trying to call the practice, which can be frustrating. But there are lots of other things as well in analyzing data, bringing data forward that will help us to make the appropriate decisions. And one of the things that I often use as an example is the airline industry. And they have a remarkable safety record as we all know, thank goodness. But if you sit in the cockpit of an airplane and you look at the instruments, all the critical data is right in front of them, unencumbered and very clearly presented because they need those data to fly the plane, and they need those data to be rapidly and easily accessible. They can get all the data they need; you look at the cockpit ceiling, it's got a thousand switches on, everything they need is there, but the critical data is never hidden and always presented. I don't think that that in fact is the way our electronic health records are set up. In fact, quite the contrary. And all of us spend a fair amount of time looking for data and so on because the records are complicated, and they're used by a lot of different specialists. But we can use augmented intelligence to bring all the critical data up, just like the cockpit in an airplane, to make sure that we have what we need rapidly accessible, and we don't miss anything. We don't go looking for the genomic test and can't find them and then assume they weren't done and make a decision without critical data when in fact they were done, but the data is hidden. So, I think we have a lot of options to use technology to improve our daily lives. I think it will take away some of the frustrations that lead to burnout, and we'll also make practice not only more efficient, but frankly also much safer. I think we have to work hard on this. We could partner with that technology colleagues. We at Penn are trying to do that. I know others are trying to do it as well. And I think the patients will benefit, will all benefit. Practice will be better, safer, less frustrating, and the outcomes of the patients will be better. Dr. John Sweetenham: Yeah, thanks Larry. I think your analogy with an aircraft cockpit is so perceptive and I think that that's something if we could unclutter our electronic health records and what we're seeing in front of us in at the points of care in the clinic, I agree 100% that will be such a step forward. So, thanks for sharing that. Thanks also, Larry, for discussing some of these challenges that we're going to be confronting in the next year and beyond, as well as the potential solutions. I think one thing that is really important to remember despite these challenges is something that I mentioned in the introduction to the podcast today. So, when we are all feeling a little bit disheartened because of the challenges ahead of us, it's important to remember that in 2026 there will be an estimated 20.3 million cancer survivors in the United States, which really does underline how far we've come, certainly in the time that you and I have been practicing oncology, and really important not to lose sight of that. We had a lot of challenges, but really the achievements of the last 50 years or so are pretty remarkable. It's been a real pleasure to have you on the podcast today, so thank you again for joining us and for sharing your thoughts with us. Dr. Lawrence Shulman: Thanks so much for having me, John. Dr. John Sweetenham: And thank you to our listeners for your time today. If you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. For more information on Dr. Shulman's research discussed in this episode, please see the articles below: The Future of Cancer Care in the United States—Overcoming Workforce Capacity Limitations | Health Care Workforce | JAMA Oncology | JAMA Network Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action - PubMed (nih.gov) Re-envisioning the Paradigm for Oncology Electronic Health Record Documentation by Paying for What Matters for Patients, Quality, and Research | Health Care Reform | JAMA Oncology | JAMA Network Survival As a Quality Metric of Cancer Care: Use of the National Cancer Data Base to Assess Hospital Performance - PubMed (nih.gov) Establishing effective patient navigation programs in oncology - PubMed (nih.gov) Patient Navigation in Cancer: The Business Case to Support Clinical Needs Cancer Care and Cancer Survivorship Care in the United States: Will We Be Able to Care for These Patients in the Future? - PMC (nih.gov) Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:      Dr. John Sweetenham  Dr. Lawrence Shulman     Follow ASCO on social media:       @ASCO on Twitter    ASCO on Facebook    ASCO on LinkedIn       Disclosures:      Dr. John Sweetenham:   Consulting or Advisory Role: EMA Wellness     Dr. Lawrence Shulman: Consulting or Advisory Role: Genetech Research Funding (Inst.): Celgene, Independence Blue Cross

In what we hope is the late phase of the COVID-19 pandemic, we'll take a look at other long-running issues relating to health care, healthy living, and access to care for the LGBTQ+ community. Our expert panelists for this discussion are leaders in the efforts to reach LGBTQ+ people, informing them and connecting them to appropriate health care services. About the Speakers Dr. Monica Ghandi, M.D., M.P.H., was a recipient of The Commonwealth Club's Distinguished Citizens Award in 2021. She is an infectious diseases doctor, professor of medicine and associate chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the director of the UCSF Center for AIDS Research (CFAR) and the medical director of the HIV Clinic ("Ward 86") at San Francisco General Hospital.  Craig Rouskey is the co-founder and CEO of Renegade.bio. Rouskey was also a co-founder and CSO at Pando Nutrition, an animal nutrition company. At Avant Immunotherapeutics, he worked on vaccine projects against avian influenza (H5N1) and anthrax. He co-founded the Gonorrhea Eradication Team (GET) and served as principal scientist for the Immunity Project, creating an open source vaccine against HIV. Rouskey has also served as a scientist in the Antibody Therapy Group at Novartis and in product development with the Next Generation Sequencing group at Thermofisher. Antwan Matthews, BS, serves as director of youth programs at Code Tenderloin and is a consultant. A leader in the community, he previously served as a LINCS Navigator with the San Francisco Department of Public Health. He has been an advocate on many issues connected to the National AIDS Memorial, having served on its board of directors and being a recipient of the Pedro Zamora Youth Scholarship. His work includes being a sexual and reproductive health advocate who cares deeply about the physical, emotional, and psychological health of individuals globally, especially the Black community. His career includes working at Glide and Peer HEALTH Educators. His work today continues around supporting, educating, advising, teaching, and healing people receiving health care impacted by the history of medical abuse inflicted on communities of color. Antwan uses his voice to raise issues about health and social justice. You can read some of his work here.  Dr. Alexis Petra, M.D. is the founder and CEO of TransClinique. Petra was a practicing emergency medicine physician for more than 10 years prior to founding TransClinique. In 2019, she was named one of Phoenix magazine's Top Doctors in the Valley. Dr. Petra is board-certified in emergency medicine and licensed in more than 30 states. She is a member in good standing with WPATH. Petra has been personally and professionally involved in the transgender and non-binary community for more than 20 years. She founded TransClinique in April 2020 to give back to and create a safe space for members of the community to receive care. She provides hormone replacement therapy (HRT), letters of referral, and trans life coaching across the country through telemedicine. As a trans woman herself, Alexis understands the unique needs that members of this community have and knows firsthand both the hardships and rewards of the journey. Learn more at her website.  Learn more about your ad choices. Visit megaphone.fm/adchoices

To tackle some of the burning questions and concerns in global medicine—specifically in radiology, diagnostics, and AI—Chadi hosts a Healthcare Unfiltered mainstay as well as a new guest: Saurabh Jha, MD, radiologist at the University of Pennsylvania and self-proclaimed “global radiology enthusiast,” and Prashant Warier, co-founder and the CEO of Qure AI. The trio begin by detailing the development of AI in underserved countries for the diagnosis of tuberculosis and other diseases, continue by sharing the inspiration and mission of a trip Saurabh and Prashant took to Nepal to improve the health and well-being of the Nepalese people through diagnostic AI, and finish by holding a larger conversation on screening and diagnostic concerns for other underserved populations around the world. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Global Medicine! This episode is with Lauren Bull, MD who discusses her experiences practicing in New Zealand, as well as practicing full spectrum in the US. She compares the two systems and speaks to the advantages and disadvantages of each. Great ep! Get into it! Don't forget to check out the archive of past episodes, available for free! Subscribe and share! #podcast #HealthAndWellness #MedicalPodcast #PrimaryCare #PCP #FamilyMedicine #GlobalMedicine #LifestyleMedicine #OsteopathicMedicine

The Amazon rainforest is under increasing pressure from climate change, deforestation, extractive industries like mining, and a range of human-induced factors. This episode explores the public health impacts of human-induced pressures on the Amazon, including an increased risk of yellow fever outbreaks. With Dr Anice Sallum, medical epidemiology and entomology professor at Sao Paolo University's School of Public Health, and Dr Amy Vittor, Assistant Professor in Infectious Diseases and Global Medicine at the University of Florida.

We are two and a half years into the COVID pandemic.  We've lived through lockdowns, toilet paper shortages, mask mandates, hospital surges where ICU's overflowed, a million COVID deaths, prolonged school closures, development and roll out of novel vaccines, an explosion of social isolation and loneliness, and the invention of the “zoom meeting.”  But what have we really learned over this seemingly endless pandemic other than how to make a quarantini?  Well, on today's podcast we invite Monica Gandhi to sum up the evidence to date about how best to prevent getting COVID (or at least the severe outcomes of the disease) and how to treat it, including the role of Paxlovid in symptomatic disease. Monica Gandhi is a professor of medicine and associate division chief of HIV, Infectious Diseases, and Global Medicine at UCSF & San Francisco General Hospital.  In addition to her research publications, she is a prolific writer both on social media and on media outlets like the Atlantic and the Washington Post.  Some call her an optimist or maybe a pragmatist, but I'd call her someone who inherently understands the value in harm reduction when it's clear harm elimination just ain't gonna happen. So take a listen and if you want a deeper dive into some of the references we discuss on the podcast, here is a list: Medscape article on how “COVID-19 Vaccines Work Better and for Longer Than Expected Across Populations, Including Immunocompromised Individuals” Stat news article about variants/COVID becoming more predictable A good twitter criticism of the CDC 1 in 5 COVID survivors have long COVID study NIH study about long COVID published the day before in Annals of Internal Medicine Evusheld and how it works against BA4 and BA5 Our World in Data COVID graphs

Discussion on South Korea's transition to an endemic- 한국 앤데믹으로의 전환 가능성에 대한 논의Guest: Monica Gandhi, Professor of Medicine, Division of HIV, Infectious Diseases, and Global Medicine at University of California San FranciscoSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Monica Gandhi, Infectious Disease Expert, is back on the podcast to offer us some insights on the pandemic. She covers so much in this 30-minute interview to clear up confusion and to offer the latest data. We get into everything from why certain concepts like natural immunity and endemic vs zero covid were considered controversial when she was on the show back in August and what the current thinking is today. She gives us the latest update on the current variant and masking, as well as what breakthrough covid really means. She also shares her thoughts on how we can get back to normal and why even saying that is upsetting to so many people (at least on Twitter where Dr. Gandhi regularly posts). There are a couple of articles available on the show notes page that she references. Tune in now and access the show notes at https://thegoodlifecoach.com/176 WHAT WE DISCUSS: The efficacy of the vaccines against the latest variant. Whether breakthrough infections is what it should be called when someone fully vaccinated gets the virus. The latest update on masks, which ones are most reliable, and how they can be used for protection. What endemic means and why countries are moving away from zero-covid strategies. Why natural immunity should be considered like it is in Europe and why Dr. Gandhi still recommends creating hybrid immunity with one dose if you've had it. Where we are headed and is it possible to get back to normal? She explains why it's important to have rational management moving forward. Please note that this interview was recorded on March 23, 2022 and the data changes frequently. *This interview is not to be considered medical advice. This episode is for informational and entertainment purposes only and is not intended to replace your relationship with your doctor or trusted healthcare providers. Please consult your doctor for anything dealing with your health and well-being. About Our Guest: Monica Gandhi MD, MPH is an Infectious Diseases doctor, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic (“Ward 86”) at San Francisco General Hospital. Her research focuses on HIV and women and adherence measurement in HIV treatment and prevention and most recently, on how to mitigate the COVID-19 pandemic.

On this episode of the I Look Like a Doctor podcast, I had the pleasure of interviewing Dr. Mauricio "Jimmy" Franco. He is a pediatrics resident (PGY1) at the UCSF-PLUS pediatrics residency. During our discussion about Dr. Franco's background and journey to medicine, we touched on many amazing and high-yield topics. Tune in to hear us talk about non-linear journeys, working during pre-med, finances, GPA, MCAT, medical school application experience, study strategies, finding your narrative, wellness, moving away from home, choosing a non-science major, multi-faceted identities, building your dream mentor team, personal statement writing, and more! This is a longer episode than usual but well worth the listen.Short Bio as written by Dr. Franco:My name is Mauricio “Jimmy” Franco, I was born in Los Angeles and grew up in Lancaster, CA. I am the brother of three strong mujeres and the son of Guatemalan immigrants. This mezcla of identities and experiences has helped mold me into an outspoken Queer Centro Americano.Beyond my role in medicine, l I am a writer, photographer, and activist. Finding balance in my life through community work, wellness, and family has helped me sustain my commitment to achieving a career in medicine while also nurturing my full self. I have carved a path that centers on social justice and health equity as the backbone to how I approach medicine as well as mentorship. I spent 15 plus years co-leading initiatives to transform mentorship in Latinx communities and LGBTQIA+ advocacy. My life's mission is to support those around me to live authentically and to uplift the many journey's a person can have in becoming a physician. If you are struggling with imposter syndrome know this; I graduated undergrad with a 2.57 GPA, completed a postbacc program, took the MCAT twice, completed a Master of Science in Global Medicine, and applied to Medical school twice before being admitted to medical school. I believe our journeys have the power to transform medicine and uplift others to live without shame. Medical school had its challenges, but I am proud of what I have accomplished and carry the many lessons I have learned from the communities I serve. After graduation from Michigan State University College of Human Medicine, I will be training as a pediatrician. I matched at the University of California San Francisco (UCSF) where I will continue to learn how to integrate health equity and public health into my role as a physician. Medicine needs to be radically transformed and I am grateful to my mentors for showing me that I can be a queer Guatemalan and show up as my full self wherever I go.Music by Francis TongpaladCheck out the rest of his work:Soundcloud - https://soundcloud.com/1w_uSpotify - https://open.spotify.com/artist/3VwEfXzbnf11lhaYAuuMtUApple Music - https://music.apple.com/us/artist/w-u/1526729708Bandcamp - withuu.bandcamp.comAudius - https://audius.co/1w_u

Join Katie and Ken as they welcome Dr. Mike Lauzardo, Chief of the University of Florida's Division of Infectious Diseases and Global Medicine. The group discusses the latest COVID-related challenges in collegiate athletics and considerations for navigating the pandemic going forward. Dr. Lauzardo also touches on hot topics centered on common myths, advice, and care in battling the current state of the pandemic. And the trio chats about their brews of choice heading into the new year. Welcome (0:11) Common COVID-19 Myths (0:49) Current State of COVID-19, Omicron Variant (2:11) Testing Protocol for Athletes (9:22) Speaking “Coach” (13:35) CDC Guidelines & Playing Masked Up (16:33) The Umbrella Analogy (20:35) Brews of the Month (23:02) Wrap-up (25:48) Sign-up to receive News & Brews Sports Biz notifications when new episodes are released: https://www.jmco.com/news-and-brews/ Learn more about James Moore Collegiate Athletics Services Team: https://www.jmco.com/industries/collegiate-athletics/

Dr. Monica Gandhi joins America's Roundtable co-hosts Natasha Srdoc and Joel Anand Samy and provides further insights on her recent piece, co-authohred with Jeanne Noble and published in Time Magazine — "We Can't Just Impose Restrictions Whenever COVID-19 Surges. Here's a Better Plan for 2022." Dr. Gandhi MD, MPH is Professor of Medicine; Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine; Director of the Ward 86 HIV Clinic at San Francisco General Hospital; and Director of the Center for AIDS Research at UCSF. She brings to the forefront the concerns about our children in her op-ed piece via The Wall Street Journal titled, "The Pandemic's Toll on Teen Mental Health" in which she states: "The pandemic may have taken a heavier mental toll on young people than it has on adults. As the vaccinated proportion of the population increases and the pandemic ebbs across the U.S., a different crisis demands immediate attention. The nation's health and education leaders must focus now on helping young people get past what has been a long, dark year." Dr. Gandhi also highlights key lessons learned from the pandemic as America and the world transition to the endemic phase. https://ileaderssummit.org/services/americas-roundtable-radio/ https://ileaderssummit.org/ | https://jerusalemleaderssummit.com/ America's Roundtable on Apple Podcasts: https://podcasts.apple.com/us/podcast/americas-roundtable/id1518878472 Twitter: @MonicaGandhi9 @ileaderssummit @NatashaSrdoc @JoelAnandUSA America's Roundtable is co-hosted by Natasha Srdoc and Joel Anand Samy, co-founders of International Leaders Summit and the Jerusalem Leaders Summit. America's Roundtable from Washington D.C. informs, educates, empowers and challenges the listening audience about the importance to restore, strengthen, and protect our freedoms, the rule of law, and free markets. America's Roundtable advances the ideas of freedom, the significance of freedom of speech, limited government, and the application of free market principles to solve problems. America's Roundtable presents in-depth analysis of current events and public policy issues while applying America's founding principles. America's Roundtable radio program - a strategic initiative of International Leaders Summit, focuses on America's economy, healthcare reform, rule of law, security and trade, and its strategic partnership with rule of law nations around the world. The radio program features high-ranking US administration officials, cabinet members, members of Congress, state government officials, distinguished diplomats, business and media leaders and influential thinkers from around the world. America's Roundtable is aired by Lanser Broadcasting Corporation on 96.5 FM and 98.9 FM, covering Michigan's major market and the upper Midwest, SuperTalk Mississippi Media's 12 radio stations and 50 affiliates reaching every county in Mississippi and also heard in parts of the neighboring states, including Alabama, Arkansas, Louisiana and Tennessee, and through podcast on Apple Podcasts and other key online platforms.

Monica Gandhi MD, MPH is Professor of Medicine and Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital. She's been a leading voice on COVID since the start of the Pandemic. And she believes we can weather the Omicron variant better than we did Alpha and Delta. Subscribe to Bay Current on the Audacy App, Google podcasts or Apple podcasts. Every episode of Bay Current on on the KCBS Radio YouTube page.

An update on how the unhoused community is affected by the storm. The call for public health officials to create guidelines for “de-masking” in schools. Revisiting our conversation with Sacramento Police Chief after his retirement announcement. Ballet's “Nutcracker” returns after nearly two years. Today's Guests CapRadio News Reporter Chris Nichols gives us an update on how the storm affected the unhoused community in Sacramento. Dr. Monica Gandhi, Professor of Medicine of the division of HIV, Infectious Diseases, and Global Medicine at UC San Francisco, joins us to discuss why she's encouraging public health leaders to create guidelines for “de-masking” in schools. Last week, the Sacramento Police Department announced Deputy Chief Kathy Lester will take over as Chief in 2022. Today, we revisit our August 2021 conversation with Sacramento Police Chief Daniel Hahn after announcing his retirement. Anthony Krutzkamp, Artistic/Executive Director of the Sacramento Ballet, discusses hometown Nutcracker performances this season. 

Nearly two years after Covid-19 was first detected in Wuhan, the world is still very much in a pandemic. The toughest phase may behind us, but we are still faced with the possibility of new variants of concern, waning immunity and vaccine evasion. As first-generation vaccines start to show their weaknesses, next-generation vaccines are becoming more and more important. While hundreds of vaccines are in the pipeline, there are a few frontrunners and other interesting candidates that might be meaningful additions to our Covid vaccine armamentarium. Experts discuss the current status of a number of protein-based vaccines including candidates from Novavax, Vaxine, Clover, GSK/Sanofi and others. DNA vaccines are also still an attraction with the first authorization for Zydus Cadila in India. Other mRNA vaccines might offer meaningful differentiation, while vaccines targeting the S and N protein might also have greater importance when it comes to tackling future variants. While nasal and oral vaccines seem appealing for the prevention of infection and transmission, they also have some inevitable hurdles to overcome and are still a long way off materializing. Experts discuss future manufacturing hurdles that will require greater global collaboration to achieve future vaccine production and distribution goals. Finally, experts discuss the current global status so far and forecasts for exiting the pandemic state and entering a livable endemic.  Expert Guests: -- Reynald Castaneda is the Clinical Trials Editor of GlobalData Media in London, covering drug development for investors and the pharmaceutical industry. -- Dr Maria Elena Bottazzi is the Associate Dean, National School of Tropical Medicine and Professor of Pediatrics (Tropical Medicine) and Molecular Virology and Microbiology at Baylor College of Medicine, Texas, US. She is a leading expert in vaccine development and tropical diseaes. -- Dr Deborah Fuller is a Professor of Microbiology at The University of Washington School of Medicine. A veteran vaccinologist and researcher, she has been working on vaccine development for the last 30 years with specific research around DNA and RNA technologies.  -- Dr Shabir Madhi is Dean of the Faculty of Health Sciences and Professor of Vaccinology at the University of the Witwatersrand, Johannesburg, South Africa. He is also the co-founder of the African Leadership Initiative for Vaccinology Expertise (ALIVE). -- Dr Nikolai Petrovsky is Professor of Medicine, Flinders University, Adelaide, Australia and vice-president and secretary-general of the International Immunomics Society. He is the founder of vaccine biotech, Vaxine, which has a protein based vaccine for Covid-19 in its pipeline. -- Dr Monica Gandhi is Professor of Medicine and Associate Division Chief (Clinical Operations/Education) of the Division of HIV, Infectious Diseases, and Global Medicine at University California San Francisco/San Francisco General Hospital. -- Dr Prashant Yadav is a Senior Fellow at the Center for Global Development and Affiliate Professor of Technology and Operations Management at INSEAD. Yadav has with governments and global organizations to improve medical product supply chains. Previous roles include Strategy Leader-Supply Chain at the Bill & Melinda Gates Foundation and Chair of the Market Dynamics Advisory Group of the Global Fund. -- Dr. Nadia Sam-Agudu is Associate Professor of Pediatrics (Immunology/Infectious Diseases) at the University of Maryland School of Medicine and Senior Technical Advisor at the Institute of Human Virology Nigeria. She conducts public health and implementation research in maternal and child health, with a focus on HIV and other major infectious diseases in African countries.

As the world tries to take a hold over the delta variant, we're all watching and waiting to see if the virus is going to evolve into something new. There are fears that natural selection could potentially yield a new variant that will completely escape all of our current vaccines. While these scenarios are hypothetical, experts discuss the need to be vigilant and prepared without unnecessary panic. Experts unpack the virus' evolution so far into delta and how that has impacted our goals for herd immunity. They talk about the possibilty for delta to change into a variant more transmissible or virulent, and how potentially leaky vaccines might impact or enhance the virus' evolutionary path. In August, Joe Rogan highlighted a paper on his podcast "The Joe Rogan Experience," which raised public concern that our current vaccines are potentially encouraging new potent variants to emerge. The author of that paper, Professor Andrew Read, comes on to clarify his research in chickens and where certain extrapolations can and can't be made. Meanwhile, experts discuss the possibility of vaccine pressure and the need for new vaccines and which types of vaccine development strategies might better help us get ahead of the virus' curve.  Expert Guests: -- Dr Shabir Madhi Shabir Madhi is Dean of the Faculty of Health Sciences and Professor of Vaccinology at the University of the Witwatersrand, Johannesburg, South Africa. He is also the co-founder of the African Leadership Initiative for Vaccinology Expertise (ALIVE). -- Dr Jeffrey Morris is Professor of Biostatistics and Director, Biostatistics Division at the University of Pennsylvania, US. His research focuses on developing quantitative methods to extract knowledge from biomedical big data and he set up a blog dedicated to issues concerning the Covid-19 pandemic. -- Dr Nikolai Petrovsky is Professor of Medicine, Flinders University, Adelaide, Australia and vice-president and secretary-general of the International Immunomics Society. He is the founder of vaccine biotech, Vaxine, which has a protein based vaccine for Covid-19 in its pipeline. -- Dr Monica Gandhi is Professor of Medicine and Associate Division Chief (Clinical Operations/Education) of the Division of HIV, Infectious Diseases, and Global Medicine at University California San Francisco/San Francisco General Hospital.

As governments around the world try to get their countries and economies back on track, they are starting to desperately implement a number of vaccine policies that have sometimes been questioned by society and scientists. In this episode, experts discuss the rationale around boosters, who should get them, when they are the most effective and the problems around offering third doses to individuals when many vulnerable people around the globe are still fighting for their first. Experts also talk about mandates and the debate around forcing the previously infected to be fully immunized when the data suggests otherwise. They also discuss possible mandates for children and schools, vaccine passports to live general life and cross borders as well as different countries discriminating against which vaccines are acceptable for a passport. Finally, experts talk about whether it makes scientific sense to implement such strict mandates at this stage of the pandemic given the shifting understanding around how these vaccines are actually working among communities. With the current problem of global vaccine inequity, experts question whether such mandates implemented by rich countries are ethical and fair. Expert guests: -- Dr Monica Gandhi is Professor of Medicine and Associate Division Chief (Clinical Operations/Education) of the Division of HIV, Infectious Diseases, and Global Medicine at University California San Francisco/San Francisco General Hospital. -- Dr Nikolai Petrovsky is Professor of Medicine, Flinders University, Adelaide, Australia and vice-president and secretary-general of the International Immunomics Society. He is the founder of vaccine biotech, Vaxine, which has a protein based vaccine for Covid-19 in its pipeline. -- Dr Jeffrey Morris is Professor of Biostatistics and Director, Biostatistics Division at the University of Pennsylvania, US. His research focuses on developing quantitative methods to extract knowledge from biomedical big data and he set up a blog dedicated to issues concerning the Covid-19 pandemic. -- Dr. Nadia Sam-Agudu is Associate Professor of Pediatrics (Immunology/Infectious Diseases) at the University of Maryland School of Medicine, and Senior Technical Advisor at the Institute of Human Virology Nigeria. She conducts public health and implementation research in maternal and child health, with a focus on HIV and other major infectious diseases in African countries. -- Dr Miguel O'Ryan is Professor of Microbiology and Mycology, Faculty of Medicine at the University of Chile, where is also Director of International Affairs. His research focuses on molecular and clinical aspects of enteric disease, pediatric vaccines and infection of the immunocompromised host. -- Dr Andrew Read is Professor of Biology and Entomology at PennState University, US. His research specializes in the ecology and evolutionary genetics of infectious disease, which includes the impact of vaccination on virus evolution.

Join America's Roundtable co-hosts Natasha Srdoc and Joel Anand Samy for an in-depth conversation with Dr. Monica Gandhi, an American physician and professor focusing on America's healthcare front and the efforts to address the pandemic at home, and what other nations are facing within Europe, the Middle East including Israel, and the Indo-Pacific region. Dr. Gandhi is Professor of Medicine and Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital and Medical Director of the HIV Clinic at SFGH. Dr. Gandhi's op-ed pieces: The Wall Street Journal, September 30, 2021: Covid Will Soon Be Endemic, Thank Goodness | Widespread immunity, vaccinated and natural, will bring control and a full return to normal. https://www.wsj.com/articles/covid-endemic-vaccines-measles-smallpox-pandemic-coronavirus-11633015316 The Washington Post, October 5, 2021: School quarantines keep too many kids at home — with barely any effect on covid https://www.washingtonpost.com/outlook/2021/10/05/quarantine-covid-schools-modified-test/ The Wall Street Journal, June 10, 2021: The Pandemic's Toll on Teen Mental Health | The CDC tried to spark a panic about Covid hospitalizations while ignoring the real crisis. https://www.wsj.com/articles/the-pandemics-toll-on-teen-mental-health-11623344542 New York Times, June 8, 2021: Opinion | We Must Fully Reopen Schools This Fall. Here's How. | A blueprint for the C.D.C. to bring children back to classrooms safely. https://www.nytimes.com/2021/06/08/opinion/blueprint-reopening-schools.html https://ileaderssummit.org/services/americas-roundtable-radio/ https://ileaderssummit.org/ | https://jerusalemleaderssummit.com/ America's Roundtable on Apple Podcasts: https://podcasts.apple.com/us/podcast/americas-roundtable/id1518878472 Twitter: @ileaderssummit @NatashaSrdoc @JoelAnandUSA America's Roundtable is co-hosted by Natasha Srdoc and Joel Anand Samy, co-founders of International Leaders Summit and the Jerusalem Leaders Summit. America's Roundtable radio program - a strategic initiative of International Leaders Summit, focuses on America's economy, healthcare reform, rule of law, security and trade, and its strategic partnership with rule of law nations around the world. The radio program features high-ranking US administration officials, cabinet members, members of Congress, state government officials, distinguished diplomats, business and media leaders and influential thinkers from around the world. America's Roundtable is aired by Lanser Broadcasting Corporation on 96.5 FM and 98.9 FM, covering Michigan's major market, SuperTalk Mississippi Media's 12 radio stations and 50 affiliates reaching every county in Mississippi and also heard in parts of the neighboring states, including Alabama, Arkansas, Louisiana and Tennessee, and through podcast on Apple Podcasts and other key online platforms.

Wearing a masking to protect yourself and others against the spread of the coronavirus has become something of a political, social, and emotional fireball. Should the vaccinated continue to wear them? Is a mask really necessary outdoors? So many questions remain, but the answers are hard to come by as health agencies, local officials, and even health experts seem to continually change their recommendations. On this week's episode, Monica Gandhi, MD, MPH, associate chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California San Francisco, joins us to help break down what the science shows about masks and their ability to protect us.

Dr. Monica Gandhi toured the landscape with us. The recent recall of California Governor Gavin Newsom has bipartisan roots, in dissatisfaction with the “lockdown mentality” that closed playgrounds and parks, and kept San Francisco's schools shuttered for 18 months. It was to a significant degree a “referendum on the illiberal liberals.” Once “the power of vaccines” came into force, however, California pioneered mandates, passports, and expanded testing; achieved over 80% vaccine coverage; and drove cases and deaths to exceptional lows. The future? “Immunity is the path out” to achieve control over Covid-19. Big concerns? Confused messaging around boosters terrifies the vaccinated and makes the unvaccinated believe less in vaccines. We are also witnessing rising intolerance: in our politically polarized debates over schools, vaccines, masks, and boosters, scientific discourse has lost balance and nuance.   Dr.Monica Gandhi is Professor of Medicine and Associate Chief of the Division of HIV, Infectious Diseases and Global Medicine at UCSF/San Francisco General Hospital. She also serves as the medical director of the HIV Clinic at SFGH, the famous “Ward 86.”

“When the public links climate change with their own health, they're much more likely to take action”  Dr. Sheri Weiser is a professor of medicine in the Division of HIV, Infectious Diseases, and Global Medicine at UCSF, works at Zuckerberg San Francisco General Hospital, and is a researcher for how extreme weather drives food insecurity and poor health outcomes.  She is also involved in educational initiatives in the UC system to infuse themes of climate change and sustainability into health professional education, co-launching a UC wide center on Climate Health and Equity.  Dr. Weiser redefines the role of health professionals, provides advice on how to engage with those who think climate change is not in their lane, and tangible ways to harness brilliance to combat harmful inaction. Check out The University of California Center for Climate, Health, and Equity at: climatehealth.ucsf.edu If you live in California, please join us by visiting www.ClimateHealthNow.org and introduce yourself and become a member by emailing us at: caclimatehealthnow@gmail.com If you live outside California, we recommend you find your state clinicians for climate action group by visiting the Medical Society Consortium on Climate and Health's website at: medsocietiesforclimatehealth.org/about/affiliates/

We cover the latest update on the Delta variant; what we can learn from the outbreak in vaccinated people in Provincetown, MA; the best ways to mitigate risk and protect kids too young to be vaccinated; Kids and Pfizer vaccine; what happened to the flu last year; the importance of reopening schools; the latest on masks; and getting to an endemic vs eradicating the virus. If you want to learn more the Delta variant based on the latest facts without all of the fear, then this interview is for you. Please note that this interview was recorded on August 3, 2021 and the data is changing daily so some of it will not be relevant at a future date. *This interview is not to be considered medical advice. This episode is for informational and entertainment purposes only and is not intended to replace your relationship with your doctor or trusted healthcare providers. Please consult your doctor for anything dealing with your health and well-being. About Our Guest: Monica Gandhi MD, MPH is an Infectious Diseases doctor, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. Her research focuses on HIV and women and adherence measurement in HIV treatment and prevention and most recently, on how to mitigate the COVID-19 pandemic.. Tune in now and access the show notes at thegoodlifecoach.com/141.  

We're going backward. Instead of climbing out of the pit of the pandemic, the U.S. is seeing a new surge. The highly contagious COVID-19 delta variant is causing new infections, new hospitalizations and new deaths — almost exclusively among the unvaccinated. Centers for Disease Control and Prevention Director Rochelle Walensky said last week that cases are up more than 70 percent from the previous week. Deaths, a lagging indicator, have increased 26 percent. In almost every instance, it's the unvaccinated getting sick and dying from the virus. The good news? Vaccines work. The bad news? The U.S. needs more people to get vaccinated. And trying to convince the remaining hesitant will not be a fast or easy job. What does this mean for breakthrough infections? Will cases continue to rise, and will mask mandates go back into place, as they already have in Los Angeles County? And what about kids — especially those 12 and under who aren't yet eligible to be vaccinated? Do they face another year of wearing masks in the classroom? Kerri Miller tackled those topics and more Wednesday morning with two doctors who are on the front lines of pandemic research. Guests: Dr. Monica Gandhi is a professor of medicine and associate division chief of the Division of HIV, Infectious Diseases and Global Medicine at UCSF/San Francisco General Hospital.  Dr. Tina Tan is a professor of pediatrics at the Feinberg School of Medicine at Northwestern University and an attending physician at Ann & Robert H. Lurie Children's Hospital in Chicago. To listen to the full conversation you can use the audio player above. Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts, Spotify or RSS

This is an exclusive interview with Nathan Coury. In this episode Jack and Nathan discuss the global changes that are going on by explaining with metaphors including plant medicine ceremonies. 

Join America's Roundtable co-hosts Natasha Srdoc and Joel Anand Samy for a conversation on the Covid-19 pandemic's toll on teen mental health with Monica Gandhi, MD, Professor of Medicine and Associate Division Chief (Clinical Operations/ Education) of the Division of HIV, Infectious Diseases, and Global Medicine at The University of California San Francisco General Hospital. She also serves as the medical director of the HIV Clinic at San Francisco General Hospital. Dr. Gandhi completed her M.D. at Harvard Medical School. The discussion also elevates concerns about China's culpability in the spread of the Covid-19 pandemic and the Chinese communist party's lack of transparency in revealing the origins of the virus that has caused the deaths of nearly 4 million people and affecting some 175 million cases around the world. Dr. Monica Gandhi: The Pandemic's Toll on Teen Mental Health via The Wall Street Journal https://www.wsj.com/articles/the-pandemics-toll-on-teen-mental-health-11623344542 "The Economist/YouGov found 58 percent of Americans said COVID-19 came from a Wuhan lab, up from 49 percent who said the same when the pollsters first asked the question in May of 2020. Meanwhile, 18 percent said it was "definitely or probably false" that the virus came from a Chinese lab, while 24 percent said they didn't know." - Newsweek https://ileaderssummit.org/services/americas-roundtable-radio/ https://ileaderssummit.org/ | https://jerusalemleaderssummit.com/ America's Roundtable on Apple Podcasts: https://podcasts.apple.com/us/podcast/americas-roundtable/id1518878472 Twitter: @ileaderssummit @NatashaSrdoc @JoelAnandUSA America's Roundtable is co-hosted by Natasha Srdoc and Joel Anand Samy, co-founders of International Leaders Summit and the Jerusalem Leaders Summit. America's Roundtable radio program - a strategic initiative of International Leaders Summit, focuses on America's economy, healthcare reform, rule of law, security and trade, and its strategic partnership with rule of law nations around the world. The radio program features high-ranking US administration officials, cabinet members, members of Congress, state government officials, distinguished diplomats, business and media leaders and influential thinkers from around the world. America's Roundtable is aired by Lanser Broadcasting Corporation on 96.5 FM and 98.9 FM, covering Michigan's major market, SuperTalk Mississippi Media's 12 radio stations and 50 affiliates reaching every county in Mississippi and also heard in parts of the neighboring states, including Alabama, Arkansas, Louisiana and Tennessee, and through podcast on Apple Podcasts and other key online platforms.

Dr. Maria Colon-Gonzalez obtained her medical degree at the University of Puerto Rico Science Medical Campus. She then joined Penn State to complete her residency in Family & Community Medicine. While at Penn State, she traveled abroad to gain experience in Global Medicine. This sparked a passion in Dr. Colon and she decided to complete a fellowship at Brown University in Faculty Development for Global Health. Dr. Colon then moved to South Texas joining the University of Texas Rio Grande Valley School of Medicine. She is now working for a new company called GoMD where their goal is to improve care and access to the Hispanic/Latinx population.  Very early in her career, Dr. Colon noticed the missing link in traditional medicine: that is patient empowerment for self-care. As an “ex-diabetic” Dr. Colon knows the power of lifestyle as a prescription to reverse disease. After finishing her “formal” training she became certified by the American Board of Lifestyle Medicine and completed additional training in plant-based nutrition and trauma-informed yoga. She provides comprehensive and holistic care for Hispanic patients on the US-Mexico border.  You can learn more about Dr. Colon by visiting her LinkedIn profile. All links for our guests can be found on our website: plantbaseddfwpodcast.com. Simply look for the episode, in this case, it is number 120 and you will see Dr. Colon's bio, links, and a transcript of our conversation. Linkedin Profile: https://www.linkedin.com/in/maria-colon-gonzalez-md-99b53150/ FYI Keep in mind that the Lifestyle Medicine Conference will be coming up on November 7-10 here in the Dallas area. You can learn more by visiting lmconference.org _______________________________________________________________ Visit Our Podcast Website: www.plantbaseddfwpodcast.com/ ➤YouTube channel: bit.ly/plantbaseddfw ➤Tell us what you think of our show: bit.ly/pbdfwlistener ➤Subscribe to our newsletter: bit.ly/PBDFWnewsletter ➤We are on Audible/write a review: bit.ly/plantbaseddfwaudible ➤You can support us: www.buymeacoffee.com/plantbaseddfw About Plant-Based DFW Podcast: Our podcast is recorded in Dallas, Texas, and features guests from all over the world. We focus on the main topic of LIFESTYLE MEDICINE. Our goal is to provide resources to help you take control of your health. *We address the importance of eating plant-based foods for health, immunity, and to prevent/reverse disease. *We talk about the importance of having a regular exercise routine. *We talk about stress management. *We talk about the importance of having healthy relationships. ______________________________________ More about us: ➤ Visit our website: plantbaseddfw.com/ ➤ Dr. Riz on Instagram: www.instagram.com/dr_riz_bukhari/ ➤ Dr. Riz on Facebook: www.facebook.com/DrRizBukhari/ ➤ Join our private Facebook Group: bit.ly/FBplantbaseddfw

Vaccine rates are rising, mask mandates are being repealed, so why doesn’t it feel safe to return to normal? Dr. Monica Gandhi is professor of medicine and associate division chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF San Francisco General Hospital. She joins host Krys Boyd to discuss our behavior as pandemic restrictions are lifted, how information is disseminated and ingested, and why both the political left and right have created realities beyond the guidance of the CDC.

Seeing little children suffer from various medical emergencies can be a heart wrenching experience, but you don’t have the luxury of time to wallow in pity if you’re the pediatric emergency medicine physician on duty. Nkeiruka Orajiaka grapples with this reality every day. Born and raised in Nigeria, Nkeiruka has always been passionate about medicine and she especially likes working with children – a quality that she believes to be essential for anyone who is seeking to start a career in her field. Learn more about what a day in the life of a pediatric emergency medicine physician looks like as Nkeiruka gives us a detailed description in this conversation with Dr. Richard Marn. Plus, learn about Nkeiruka’s loftier goals in global medicine and her newly found path to explore her other passions.

Almost a quarter of U.S. adults say don’t want the COVID-19 vaccine – at least not right now. Why not? And if that number doesn’t budge, what does it mean for our efforts to reach the elusive goal of herd immunity? Guests: Dr. William Schaffner is a professor in the Division of Infectious Diseases at Vanderbilt University. Dr. Monica Gandhi is a professor of medicine and associate division chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/San Francisco General Hospital.

The vaccines are here, and they're amazing. But there's still so much pessimism and confusion about how effective these vaccines actually are, which ones are "best," and what anyone can actually do after they've been vaccinated. This is a special episode, to get you justifiably excited about the rest of the year, and your life going forward. Share it with friends and family who are doubtful or scared, because Dr. Monica Gandhi, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at UCSF, has the credentials and the knowledge required to prescribe some much-needed optimism.@MonicaGandhi9How Do mRNA Vaccines Work? Here's What You Should Know - Johns Hopkins YouTubeHow the Oxford-AstraZeneca Vaccine Works - The New York TimesUniversity of Pennsylvania mRNA Biology Pioneers Receive COVID-19 Vaccine Enabled by their Foundational Research - Penn Medicine----------Email: newliberalspodcast@gmail.comTwitter: @NewLiberalsPod

Cassie Angu is a community doula and Family Planning Health Worker dedicated to eradicating the health disparities Black and minority women/birthers face. She started her academic career at the University of Florida, majoring in Telecommunications, focusing her studies on Media and Society. After graduating, she studied at the University of Southern California, where she obtained a Master's degree in Global Medicine. Since obtaining her master's degree, she has worked in community health in South Central Los Angeles and Trenton, NJ. She balances her case management work with her community doula business and has aspirations to become a Women's Health Nurse Practitioner and Certified Nurse Midwife to further advocate for those who need it most. On this episode, we discussed the medical system pertaining to birth in the US, being a doula, and her business “The Hood Doula”. Don't miss out on this great interview! Check out the social media pages for the podcast below: Instagram: @GreenRulesEverything Twitter: @GreenRulesEvery Facebook: Green Rules Everything Check out the podcast on other platforms at the link below: https://linktr.ee/GreenRulesEverything

In this final and tenth episode, we'll tackle some of the last lingering questions that we all have around the vaccines and how the future might look as we navigate these uncharted pandemic waters. Experts first discuss new interim datasets from Johnson and Johnson and Novavax, notably their results on preventing severe disease, hospitalizations and deaths, and how they might fit into the vaccine paradigm. We'll break down why some EU countries have made the surprise recent decision not to administer AstraZeneca's vaccine to people over 65. Meanwhile, Russia's Sputnik-V now has a lot more data and we'll see how this vaccine measures up on the global scale of vaccines. Experts discuss vaccine utility in the real world and the debate around infection and transmission, delaying the second dose to get first doses out quicker and mixing different vaccine brands under extenuating circumstances. Safety remains a big question as the media and social media continue to flag individual cases of severe side-effects and deaths, but we'll look at the data and statistics and how to critically think about the overall safety profile of the vaccine (and when not to panic). Finally, this episode will tackle important future questions such as the need to vaccinate children and how things might look as we attempt to get back to being a global community with travel. Expert Guests: -- Dr Jeffery Morris is Professor of Biostatistics and Director, Biostatistics Division at the University of Pennsylvania. His research interests focus on developing quantitative methods to extract knowledge from biomedical big data. -- Dr Monica Gandhi is Professor of Medicine and Associate Division Chief (Clinical Operations/Education) of the Division of HIV, Infectious Diseases, and Global Medicine at University California San Francisco/San Francisco General Hospital. -- Dr Gayani Tillekeratne is Assistant Professor of Medicine and Assistant Research Professor of Global Health at Duke University. She was a co-investigator on the clinical trials of both Johnson & Johnson and AstraZeneca's vaccine in the US. -- Dr Nikolai Petrovsky is Professor of Medicine, Flinders University, Adelaide and vice-president and secretary-general of the International Immunomics Society. He is the founder of vaccine biotech, Vaxine, which has a protein based candidate in early development for Covid-19. -- Dr Saul Faust is Professor of Paediatric Immunology and Infectious Diseases and Director of the Southampton NIHR Wellcome Trust Clinical Research Facility at the University of Southhampton. He is heavily involved in UK paedatric vaccine trials. -- Dr Mary-Louise McLaws is Professor of Epidemiology at the University of New South Wales and is also a member of the World Health Organization (WHO) Health Emergencies Program Experts Advisory Panel for Infection Prevention and Control Preparedness, Readiness and Response to COVID-19.

In this ninth episode, we'll tackle the different conundrums we face with the emergence of new and highly transmissible SARS-COV-2 variants. Get ready to delve into some thought provoking scientific concepts when it comes to how this virus appears to be evolving and where we stand with our current and future vaccination goals. The episode parses out the most worrisome mutations, how they were able to evolve and why they are such a concern. Experts talk about recent data from Johnson & Johnson and Novavax, which are tell tale signs of the issues we have ahead. They also discuss where our currently authorized vaccines - Pfizer, Moderna, AstraZeneca -- stand to combat the new variants. We'll explore what manufactures are doing to keep up with new mutations and the various challenges in chasing a moving target. While experts agree that this will probably not be a once in a lifetime vaccination, they make comparisons to seasonal influenza and remain debated on how often we might need to revaccinate. Finally, experts discuss the best approach forward with both the vaccines and prudent social behaviors to ensure that we don't lose this pandemic battle due to complacency. Expert Guests: -- Dr Mary-Louise McLaws is Professor of Epidemiology at the University of New South Wales and is also a member of the World Health Organization (WHO) Health Emergencies Program Experts Advisory Panel for Infection Prevention and Control Preparedness, Readiness and Response to COVID-19. -- Dr Monica Gandhi is Professor of Medicine and Associate Division Chief (Clinical Operations/Education) of the Division of HIV, Infectious Diseases, and Global Medicine at University California San Francisco/San Francisco General Hospital. -- Dr Nikolai Petrovsky is Professor of Medicine, Flinders University, Adelaide and vice-president and secretary-general of the International Immunomics Society. He is the founder of vaccine biotech, Vaxine, which has a protein based candidate in early development for Covid-19. -- Verity Hill is an evolutionary biologist at the University of Edinburgh and is currently completing her PhD using genomic epidemiology to study the spread of Ebola in West Africa. She has authored a number of papers on the evolution of SARS-COV2 with the world's top researchers in the field.

Episode 8 of The Master Clinician Project, featuring Dr. Monica Gandhi: Infectious disease and HIV medicine specialist, Professor of Medicine at the UCSF School of Medicine, and Associate Chief of the Division of HIV, Infectious Diseases, and Global Medicine at the Zuckerberg San Francisco General Hospital.

Featured Interview: Wearing masks for COVID-19 prevention and herd immunity -마스크 착용과 코로나19 집단면역 Guest: Dr. Monica Gandhi, Professor of Medicine, Associate Chief of the Division of HIV, Infectious Diseases and Global Medicine at the University of California San Francisco